Zymeworks Inc.
ZYME
$22.88
-$0.35-1.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -90.89% | -43.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -90.89% | -43.33% | |||
| Cost of Revenue | -12.21% | 3.28% | |||
| Gross Profit | -260.62% | -155.78% | |||
| SG&A Expenses | 9.09% | -5.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.15% | 0.66% | |||
| Operating Income | -99.69% | -3,180.42% | |||
| Income Before Tax | -127.08% | -957.16% | |||
| Income Tax Expenses | -120.21% | 818.28% | |||
| Earnings from Continuing Operations | -110.23% | -946.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -110.23% | -946.01% | |||
| EBIT | -99.69% | -3,180.42% | |||
| EBITDA | -109.51% | -1,231.37% | |||
| EPS Basic | -111.44% | -939.94% | |||
| Normalized Basic EPS | -128.33% | -951.41% | |||
| EPS Diluted | -109.66% | -972.58% | |||
| Normalized Diluted EPS | -128.33% | -976.16% | |||
| Average Basic Shares Outstanding | -0.57% | 0.57% | |||
| Average Diluted Shares Outstanding | -0.58% | -2.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||